KD Logo

Maxim Group gives a Buy recommendation for ATAI Life Sciences N.V. (ATAI)

ATAI Life Sciences N.V.’s recently made public that its 10% Owner ATAI Life Sciences N.V. unloaded Company’s shares for reported $16.09 million on Sep 26 ’24. In the deal valued at $6.05 per share,2,660,000 shares were sold. As a result of this transaction, ATAI Life Sciences N.V. now holds 6,905,774 shares worth roughly $8.01 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Brand Florian sold 151,303 shares, generating $290,502 in total proceeds. Upon selling the shares at $1.92, the insider now owns 328,697 shares.

Before that, Johnson Anne Nagengast sold 27,410 shares. ATAI Life Sciences N.V. shares valued at $50,708 were divested by the Chief Financial Officer at a price of $1.85 per share. As a result of the transaction, Johnson Anne Nagengast now holds 73,590 shares, worth roughly $85364.4.

Maxim Group upgraded its ATAI Life Sciences N.V. [ATAI] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Loop Capital’s analysts, who began to cover the stock in early November with a ‘”a Buy”‘ rating. Maxim Group began covering ATAI with “Buy” recommendation on November 30, 2021. ROTH Capital started covering the stock on November 11, 2021. It rated ATAI as “a Buy”.

Price Performance Review of ATAI

On Friday, ATAI Life Sciences N.V. [NASDAQ:ATAI] saw its stock jump 9.43% to $1.16. Over the last five days, the stock has lost -0.85%. ATAI Life Sciences N.V. shares have fallen nearly -17.73% since the year began. Nevertheless, the stocks have fallen -11.45% over the past one year. While a 52-week high of $2.85 was reached on 04/04/24, a 52-week low of $1.02 was recorded on 10/03/24. SMA at 50 days reached $1.2728, while 200 days put it at $1.6334.

Levels Of Support And Resistance For ATAI Stock

The 24-hour chart illustrates a support level at 1.0900, which if violated will result in even more drops to 1.0200. On the upside, there is a resistance level at 1.2000. A further resistance level may holdings at 1.2400. The Relative Strength Index (RSI) on the 14-day chart is 44.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0760, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 57.69%. Stochastics %K at 18.19% indicates the stock is a buying.

How much short interest is there in ATAI Life Sciences N.V.?

A steep rise in short interest was recorded in ATAI Life Sciences N.V. stocks on 2024-09-13, growing by 54609.0 shares to a total of 9.63 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 9.57 million shares. There was a rise of 0.57%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on October 18, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $40 price target.

Most Popular